Today I’m joined by Zoe Diana Draelos, MD, a research and board-certified clinical dermatologist and chief medical editor of Dermatology Times® from Durham, North Carolina. She details the process of her new book, Cosmetic Dermatology: Procedures and Practice , which will be releasing in the United States in April of 2022.
Today I’m joined by James Beckman, MD. Dr. Beckman is a Biochemist, Board Certified Plastic Surgeon and Adjunct, Associate Clinical Professor-Dermatology Department at the University of Arkansas Medical School. He is also the Founder of Therapon Skin Health. Beckman is the creator of a topical application that stops the progression of a first or second degree burn. We discuss the science behind this burn reversal method, the complexities of working with burned skin, and what needs to be consider...
Shay Moinuddin, MHA, CANS, RN, an aesthetic nurse specialist and clinical manager at the Few Institute in Chicago, Illinois, talks about stackable aesthetic treatments, how the aesthetic world has changed in the last 10 years, and how allied health care workers should be utilized in the practice.
Today we are joined by Dr. Maryanne Makredes Senna, MD, assistant professor of dermatology at Harvard Medical school, and director of the Mass General Hospital Hair Loss Clinic and clinical research trials for hair loss disorders in Boston, Massachusetts. We discuss androgenetic alopecia or AGA, which is a common form of hair loss in both men and women. In men, this condition is also known as male-pattern baldness. We dive into current treatment challenges, new regeneration devices, and how to h...
Managing editor of Dermatology Times, Mary Scoviak, is joined by Candrice Heath, MD, FAAP, FAAD a dermatologist and assistant professor of dermatology at the Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, to discuss relating to patients with textured hair.
This episode of The Cutaneous Connection podcast, sponsored by Incyte, explores the world of vitiligo. From symptoms to current treatment dissatisfaction and the latest research, Pearl Grimes, MD, FAAD, explains where we are now with this pigmentary disorder and where we are headed.
In this episode, we sit down with the OJM Group from Cincinnati, Ohio, to discuss qualified retirement plans and how many dermatology practices could be saving money.
We dive into the background of the “The Full Spectrum of Dermatology: A Diverse and Inclusive Atlas.” Adam Friedman, MD, and Misty Eleryan MD, MS, describe their process to creating this new dermatologic resource.
This episode of The Cutaneous Connection podcast, Gary Linkov, MD, dives into the topic of hair loss.
In this episode, Marc Serota, MD, discusses his research regarding type 2 inflammation, the future of treating it as 1 condition or 2, and why physicians should educate their patients about this type of inflammation.
This episode highlights findings from an investigative study exploring the molecular targeting of biologics for psoriasis, as well as discusses the interleukin(IL)-17 class of biologics, how this class compares to other classes such as IL-23 and TNFα, and how bimekizumab sets itself apart from other biologics in the pipeline for psoriasis.
This episode takes a deep dive in the recent delay in approval for multiple JAK inhibitor drugs for treatment of inflammatory skin conditions such as psoriasis and atopic dermatitis. Mark Lebwohl, MD, discusses the impact of the delay, as well as the benefits of JAK inhibitors for inflammatory skin diseases, and an outlook for the future of this drug class.
In this episode, Assistant Editor Linda Stocum sits down with Jennifer Powers, MD, board certified dermatologist and associate professor of dermatology at the University of Iowa, to discuss her recent research exploring how diet and supplements affect patients with mild psoriasis.
In this episode, Alberto Pappo, MD, director, St. Jude Solid Tumor Division, discusses a registry he helped create aimed at helping physicians better understand pediatric melanoma called Molecular Analysis of Childhood MELanocytic Tumors (MACMEL).
In this episode, we provide an update on a story we broke regarding benzene contamination being detected in various sunscreens and after-sun care products. Now, Johnson & Johnson has conducted its own internal testing and is recalling 5 different aerosol sunscreen products from Neutrogena and Aveeno. Listen as Christopher Bunick, MD, explains what this means for the sun protection industry and the next steps for the FDA.
The introduction of artificial intelligence into dermatology has been met with mixed emotions from the medical community. In this episode, Ade Adamson, MD, MPP, explains the benefits and detriments of the application, accuracy, and potential racial diagnostic bias.
This episode dives into how health care policy impacts gender and sexual minority patients, including exploring the Affordable Care Act (ACA) and Medicaid expansion, and identifying state and federal nondiscrimination protections that help defend equal access to health care for this patient population.
This episode will highlight some breaking news coming out of the sun protection world with a report by Valisure, an independent lab dedicated to batch testing medications before they reach consumers, which found in a recent test that 78 different sunscreen and after-sun care products were contaminated with benzene, a potential carcinogen.
In this episode, we take a look back at what happened at the American Academy of Dermatology Virtual Meeting Experience 2021 (AAD VMX 2021), including exclusive interviews with two KOLs about their presentations regarding climate change and new data on biologics for psoriasis.
With the summer months quickly approaching, we’re discussing the importance of skin cancer screenings, as well as encouraging regular sun protection usage among patients. This episode also touches on the role of telemedicine in skin cancer screenings, top product recommendations for sun protection and tips on managing patient expectations if the patient is diagnosed with skin cancer.
Nicole Hayre, MD, FAAD, discusses her research on the link between the "love hormone" oxytocin and younger-looking skin.
In this episode, we discuss the residency match process with Jay Wofford, MD, including how the entire process works, tips on what to do and what not do, questions you should ask yourself and what to do if you don’t match.
Angelo Landriscina, MD, FAAD, discusses how to care for your LGBTQ+ patients while also effectively addressing their different dermatologic needs.
In this episode, Gary Salman, CEO of Black Talon Security, details how to best protect your practice from data breaches and cybercriminals, as well as the risks of not implementing cybersecurity measures into your practice and what to do if a data or email breach occurs.
Angelo Landriscina, MD, board-certified dermatologist and popular TikToker, discusses the recent rise in influence that TikTok has had over the beauty and skincare industry. From creating popular trends that may or may not be great for the skin, to causing skincare brands to explode, or in other cases, implode. One thing is for sure, this social media platform is definitely setting the tone for the future of the dermatology industry.
Recent reports have been surfacing in regard to adverse reactions in dermal fillers patients who have also received the COVID-19 vaccine. Whitney Bowe, MD, New York City, New York, discusses this phenomenon and provides some tips for preventing and treating these side effects.
Esther Freeman, MD, PhD, details how her and her fellow colleagues banded together to create a COVID-19 dermatology registry in just eight days. The registry has since seen over 1,000 submissions from frontline clinicians located in 40 countries, helping to identify and diagnose active COVID-19 through submitted skin findings.
Since the start of the pandemic, there has been a rise in dermatoses in healthcare workers related to occupational use of personal protective equipment (PPE). Rachel Evers-Meltzer, MD, MPH, discusses her cross-sectional survey investigating what types of dermatoses were most commonly seen in the health care spear and suggests possible treatments.
The aesthetics industry saw a massive boom during the COVID-19 pandemic for both invasive and non-invasive procedures. Amir Karam, M.D., San Diego, Calif., reveals what caused this increase in demand for aesthetics procedures and discusses the outlook for future of the industry.
Perceptions of antibiotics and potential antibiotic resistance have caused some physicians to be wary of the drug class when prescribing an acne treatment regimen. Christopher Bunick, M.D., Ph.D., clears the air around antibiotic use for acne and discusses his research of narrow-spectrum antibiotics.
